Acute Phase Protein Lipocalin-2 Is Associated with Formalin-induced Nociception and Pathological Pain
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Lipocalin-2 (LCN2) is an acute-phase protein induced by injury, infection, or other inflammatory stimuli. LCN2 binds small hydrophobic ligands and interacts with cell surface receptor to regulate diverse cellular processes. The role of LCN2 as a chemokine inducer in the central nervous system (CNS) has been previously reported. Based on the previous participation of LCN2 in neuroinflammation, we investigated the role of LCN2 in formalin-induced nociception and pathological pain. Formalin-induced nociceptive behaviors (licking/ biting) and spinal microglial activation were significantly reduced in the second or late phase of the formalin test in Lcn2 knockout mice. Likewise, antibody-mediated neutralization of spinal LCN2 attenuated the mechanical hypersensitivity induced by peripheral nerve injury in mice. Taken together, our results suggest that LCN2 can be therapeutically targeted, presumably for both prevention and reversal of acute inflammatory pain as well as pathological pain.
Abstract
Lipocalin-2 (LCN2) is an acute-phase protein induced by injury, infection, or other inflammatory stimuli. LCN2 binds small hydrophobic ligands and interacts with cell surface receptor to regulate diverse cellular processes. The role of LCN2 as a chemokine inducer in the central nervous system (CNS) has been previously reported. Based on the previous participation of LCN2 in neuroinflammation, we investigated the role of LCN2 in formalin-induced nociception and pathological pain. Formalin-induced nociceptive behaviors (licking/ biting) and spinal microglial activation were significantly reduced in the second or late phase of the formalin test in Lcn2 knockout mice. Likewise, antibody-mediated neutralization of spinal LCN2 attenuated the mechanical hypersensitivity induced by peripheral nerve injury in mice. Taken together, our results suggest that LCN2 can be therapeutically targeted, presumably for both prevention and reversal of acute inflammatory pain as well as pathological pain.
참고문헌 (38)
- Nathan, C, "Points of control in inflammation", Nature, 420, pp.846~852 (2002)
- Mithilesh Kumar Jha, "Glia as a Link between Neuroinflammation and Neuropathic Pain", Immune Network, 12(2), pp.41~47 (2012), 대한면역학회
- Lyman, M., "Neuroinflammation: The role and consequences", Neurosci. Res (2013)
- Campbell, J. N., "Mechanisms of neuropathic pain", Neuron, 52, pp.77~92 (2006)
- Scholz, J., "The neuropathic pain triad: neurons, immune cells and glia", Nat. Neurosci, 10, pp.1361~1368 (2007)
- Watkins, L. R., "Glial activation: a driving force for pathological pain", Trends Neurosci, 24, pp.450~455 (2001)
- Jeon, S., "Role of lipocalin-2-chemokine axis in the development of neuropathic pain following peripheral nerve injury", J. Biol. Chem, 288, pp.24116~24127 (2013)
- Ji, R. R., "Glia and pain: Is chronic pain a gliopathy?", Pain (2013)
- Milligan, E. D., "Pathological and protective roles of glia in chronic pain", Nat. Rev. Neurosci, 10, pp.23~36 (2009)
- Inoue, K., "Microglia and neuropathic pain", Glia, 57, pp.1469~1479 (2009)
- Gao, Y. J., "Chemokines, neuronal-glial interactions, and central processing of neuropathic pain", Pharmacol. Ther, 126, pp.56~68 (2010)
- Raghavendra, V., "Anti-hyperalgesic and morphine-sparing actions of propentofylline following peripheral nerve injury in rats: mechanistic implications of spinal glia and proinflammatory cytokines", Pain, 104, pp.655~664 (2003)
- Woolf, C. J., "Central sensitization: implications for the diagnosis and treatment of pain", Pain, 152, pp.S2~S15 (2011)
- Cowland, J. B., "Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans", Genomics, 45, pp.17~23 (1997)
- Hraba-Renevey, S., "SV40-induced expression of mouse gene 24p3 involves a post-transcriptional mechanism", Oncogene, 4, pp.601~608 (1989)
- Flower, D. R., "The lipocalin protein family: structure and function", Biochem. J, 318(Pt 1), pp.1~14 (1996)
- Nilsen-Hamilton, M., "Tissue involution and the acute phase response", Ann. N. Y. Acad. Sci, 995, pp.94~108 (2003)
- Poh, K. W., "Comprehensive gene expression profiling in the prefrontal cortex links immune activation and neutrophil infiltration to antinociception", J. Neurosci, 32, pp.35~45 (2012)
- Mucha, M., "Lipocalin-2 controls neuronal excitability and anxiety by regulating dendritic spine formation and maturation", Proc. Natl. Acad. Sci. U. S. A, 108, pp.18436~18441 (2011)
- Lee, S., "A dual role of lipocalin 2 in the apoptosis and deramification of activated microglia", J. Immunol, 179, pp.3231~3241 (2007)
- Lee, S., "Lipocalin-2 is an autocrine mediator of reactive astrocytosis", J. Neurosci, 29, pp.234~249 (2009)
- Lee, S., "Regulation by lipocalin-2 of neuronal cell death, migration, and morphology", J. Neurosci. Res, 90, pp.540~550 (2012)
- Lee, S., "Lipocalin-2 Is a chemokine inducer in the central nervous system: role of chemokine ligand 10 (CXCL10) in lipocalin-2-induced cell migration", J. Biol. Chem, 286, pp.43855~43870 (2011)
- Flo, T. H., "Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron", Nature, 432, pp.917~921 (2004)
- Nairz, M., "Absence of functional Hfe protects mice from invasive Salmonella enterica serovar Typhimurium infection via induction of lipocalin-2", Blood, 114, pp.3642~3651 (2009)
- Hylden, J. L., "Intrathecal morphine in mice: a new technique", Eur. J. Pharmacol, 67, pp.313~316 (1980)
- Decosterd, I., "Spared nerve injury: an animal model of persistent peripheral neuropathic pain", Pain, 87, pp.149~158 (2000)
- Tegeder, I., "GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence", Nat. Med, 12, pp.1269~1277 (2006)
- Chaplan, S. R., "Quantitative assessment of tactile allodynia in the rat paw", J. Neurosci. Methods, 53, pp.55~63 (1994)
- Dixon, W. J., "Efficient analysis of experimental observations", Annu. Rev. Pharmacol. Toxicol, 20, pp.441~462 (1980)
- Hunskaar, S., "The formalin test in mice: dissociation between inflammatory and non-inflammatory pain", Pain, 30, pp.103~114 (1987)
- Latremoliere, A, "Central sensitization : a generator of pain hypersensitivity by central neural plasticity. J", J. Pain, 10, pp.895~926 (2009)
- Woolf, C. J., "Neuronal plasticity: increasing the gain in pain", Science, 288, pp.1765~1769 (2000)
- Austin, P. J., "The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines", J. Neuroimmunol, 229, pp.26~50 (2010)
- Hashioka, S., "Glia: an important target for anti-inflammatory and antidepressant activity", Curr. Drug Targets, 14, pp.1322~1328 (2013)
- Skaper, S. D., "Microglia and mast cells: two tracks on the road to neuroinflammation", FASEB J, 26, pp.3103~3117 (2012)
- Vega-Avelaira, D., "Inflammation-induced hyperalgesia and spinal microglia reactivity in neonatal rats", Eur. J. Pain, 17, pp.1180~1188 (2013)
- Nowak, L., "Pentoxifylline modifies central and peripheral vagal mechanism in acute and chronic pain models", Folia Med. Cracov, 52, pp.83~95 (2012)
